Intrasal naltrexone - Opiant Pharmaceuticals

Drug Profile

Intrasal naltrexone - Opiant Pharmaceuticals

Alternative Names: OPNT 002

Latest Information Update: 10 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Opiant Pharmaceuticals
  • Class Analgesics; Cyclopropanes; Drug withdrawal therapies; Irritable bowel syndrome therapies; Morphinans; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Alcoholism

Most Recent Events

  • 10 Aug 2017 Chemical structure information added
  • 20 Jul 2017 Pharmacokinetics data from a phase I trial in Alcoholism released by Opiant Pharmaceuticals
  • 28 Jun 2017 Opiant Pharmaceuticals in-licenses Intravail® drug delivery technology from Aegis Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top